GGrantIndex
Sort

40,608 grants matching prostate cancer

Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer

$335,670
Phuoc T. Tran · Johns Hopkins University · R01 · FY2017 · CA

Structure-Functions Studies of Twist1-induced Radioresistance in Lung Cancer

$335,670
Phuoc T. Tran · Johns Hopkins University · R01 · FY2016 · CA

A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis

$335,661
Zijie Sun · Stanford University · R01 · FY2011 · CA

GEISINGER CLINICAL ONCOLOGY PROGRAM

$335,658
Geisinger Medical Center · U10 · FY2001 · CA

Refining castration use for recurrent prostate cancer

$335,650
Alexander Tsodikov · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAs

$335,635
Chengfeng Yang · Michigan State University · R01 · FY2014 · ES

Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations

$335,625
Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

A CLINICAL TRIAL WITH FINASTERIDE AND SELENIUM

$335,614
James Marshall · Roswell Park Cancer Institute Corp · P01 · FY2009 · CA

Effects of extracellular vesicles on miRNA activity in the skin

$335,599
My Georgia Mahoney · Thomas Jefferson University · R01 · FY2021 · AR

MECHANISM OF SELENIUM POTENTIATION OF FINASTERIDE EFFICACY

$335,598
Clement C Ip · Roswell Park Cancer Institute Corp · P01 · FY2011 · CA

Omega-3 PUFA-gene interaction in prostate cancer

$335,590
Yong Q Chen · Wake Forest University Health Sciences · R01 · FY2013 · CA

Protein Biosensor Arrays Based on Nanomaterials

$335,574
James F. Rusling · University Of Connecticut Storrs · R01 · FY2014 · EB

The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma

$335,540
Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · CA

Novel Radioimmunotherapy Strategies for Prostate Cancer

$335,539
Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2023 · CA

Enhancing anti-neoplastic activity of metformin in prostate cancer

$335,504
Xiaoqi Liu · University Of Kentucky · R01 · FY2020 · CA

Common Chromosomal Inversions and Genomic Variability

$335,500
University Of California Los Angeles · R01 · FY2005 · GM

Common Chromosomal Inversions and Genomic Variability

$335,500
University Of California Los Angeles · R01 · FY2004 · GM

Common Chromosomal Inversions and Genomic Variability

$335,500
University Of California Los Angeles · R01 · FY2003 · GM

MOLECULAR PROFILING OF PROSTATE CANCER SPECIMENS USING MULTICOLOR QUANTUM DOTS

$335,490
University Of Washington · · FY2008 · Department of Defense

Unraveling the regulatory circuits that drive Merkel cell carcinoma

$335,423
Megha Padi · University Of Arizona · R01 · FY2023 · CA

'Fat'Nucleosides and Nucleotides

$335,406
University Of Maryland Balt Co Campus · R01 · FY2005 · AI

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

$335,385
Peter H. Gann · University Of Illinois At Chicago · R01 · FY2014 · CA

Thermoscientific TSQ Vantage Mass Spectrometer

$335,371
Leland H Hartwell · Fred Hutchinson Cancer Research Center · S10 · FY2010 · RR

Microenvironmental drivers of indolent to aggressive prostate cancer switch mediated by combined MYC Activation and PTEN loss

$335,337
Srinivasan Yegnasubramanian · Johns Hopkins University · U54 · FY2022 · CA

Mechanisms of prostate cancer prevention by lycopene

$335,294
University Of Illinois At Chicago · R01 · FY2003 · CA